Funda Meric-Bersntam

108PUBLICATIONS
888CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (108)

|Aug 26, 2026
Molecular Response Assessment From Circulating Tumor DNA in Patients With Ovarian Cancer Treated With the WEE1 Inhibitor Azenosertib.

|Aug 18, 2026
Proteogenomic profiling identifies FGFR2b as a prevalent cell-surface target in intrahepatic cholangiocarcinoma.

|Jul 27, 2026
Clinical Impact of Mismatch Repair Gene Mutation-Based Alert on Immunotherapy Decision Making Across Patients With Cancer.

|Jul 24, 2026
Antibody-drug conjugates in solid tumors: Efficacy, challenges, and opportunities.

|Jul 13, 2026
Application of a translational research platform to unveil efficacy signals and mechanisms of resistance of FGFR inhibitors in multiple FGFR-altered solid tumors.

|May 15, 2026
Trastuzumab deruxtecan in HER2-expressing gynecologic cancers from DESTINY-PanTumor02: antitumor activity, safety, and exploratory biomarker analyses.

Pageof 18

Frequent Collaborators

17 joint publications

Timothy Anthony Yap

15 joint publications

Aung Naing

15 joint publications

Jordi Rodon Ahnert

12 joint publications

Siqing Fu